CDT EQUITY INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
CDT EQUITY INC. (CDT) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $200.00 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-08.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-09-08
- CDT EQUITY INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $200.00K, a 0.00% change year-over-year.
- CDT EQUITY INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $200.00K, a 0.00% change year-over-year.
- CDT EQUITY INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $1.60M, a 349.44% increase year-over-year.
- CDT EQUITY INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $200.00K, a 58.51% decline year-over-year.
- CDT EQUITY INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $199.00K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K S-1 · filed 2026-09-08 | $400.00K S-1 · filed 2026-09-08 | ||||
| 2026-03-31 | $200.00K 10-Q · filed 2026-07-15 | |||||
| 2025-09-30 | $1.60M 10-Q · filed 2025-11-13 | $1.80M derived: sum of 2 quarters · filed 2026-09-08 | $2.00M 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $200.00K S-1 · filed 2026-09-08 | $160.00K 10-Q · filed 2025-08-14 | $400.00K S-1 · filed 2026-09-08 | $394.00K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $200.00K 10-Q · filed 2026-07-15 | |||||
| 2024-09-30 | $356.00K 10-Q · filed 2025-11-13 | $838.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.27M 10-Q · filed 2025-11-13 | $1.46M derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $482.00K 10-Q · filed 2025-08-14 | $914.00K 10-Q · filed 2025-08-14 | $1.10M derived: sum of 3 quarters · filed 2025-08-14 | $1.11M derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $431.00K 10-Q/A · filed 2024-11-14 | $620.00K derived: sum of 2 quarters · filed 2024-11-14 | $630.00K derived: sum of 3 quarters · filed 2024-11-14 | |||
| 2023-12-31 | $189.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $199.00K derived: sum of 2 quarters · filed 2024-11-14 | $199.00K 10-K · filed 2024-04-16 | |||
| 2023-09-30 | $10.00K 10-Q · filed 2024-11-14 | $10.00K 10-Q · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |